OP JAK – running

RRF – EXCELES programme – running

Horizon Europe – running
Horizon 2020 – running
OP VVV – running
OP PIK – running
OP VaVpI v Třeboni – ended
OP VaVpi – ended
OP PK – ended
OP VK – ended

 

—— OP JAK ——

 

Project title:

Talking microbes – understanding microbial interactions within One Health framework

  

Provider	MŠMT
Operational Program	Operační program Jan Amos Komenský
Project number	CZ.02.01.01/00/22_008/0004597
Project duration	1.1.2024 – 30.6.2028
Beneficiary	Mikrobiologický ústav AV ČR
Participants	VŠCHT v Praze, PřF UK v Praze

 

Objectives of the project:

The most important player in the field of microbiology in the Czech Republic, together with two domestic partners, will join forces with the world’s leading research institutions in order to decipher the processes behind the establishment and development of microbiomes in various hosts (plants, fungi and animals, including humans), behind the mechanisms of information exchange between microbes and their hosts, and between microbes themselves, which define their role in host health and ecosystem health. The output will be innovative applications in medicine and ecology..

The project is financially supported by the European Union.

 

 

_________________________________________________________________________________________

 

Project title:

AdAgrif – Advanced methods of greenhouse gases emission reduction and sequestration in agriculture and forest landscape for climate change mitigation

 

Provider	MŠMT
Operational Program	Operační program Jan Amos Komenský
Project number	CZ.02.01.01/00/22_008/0004635
Project duration	1.7.2023 – 30.6.2028
Beneficiary	Ústav výzkumu globální změny AV ČR
Participants	Mikrobiologický ústav AV ČR, ČZU v Praze

 

Objectives of the project:

International AdAgriF scientific team aims to turn agriculture and forestry into long-term sinks and stocks of carbon and prevent avoidable emissions of CO2, N2O, and CH4. This will be achieved by greatly modernized infrastructure and three transdisciplinary research WPs spanning from molecules to landscape and society. The research will be imbedded in extensive network of excellent collaborating institutes fostering the growth of all participating scientists and reducing the research risk.

The project is financially supported by the European Union.

 

 

_________________________________________________________________________________________

 

Project title:

MSCA Fellowships CZ No. 2 (Institute of Microbiology of the CAS, v. v. i.)

Provider	Ministry of Education, Youth and Sports
Operational Program	Johannes Amos Comenius Programme
Project number	CZ.02.01.01/00/22_010/0006118
Project duration	1.10.2023 – 31.12.2025
Beneficiary	Institute of Microbiology of the CAS, v.v.i.

 

Objectives of the project:

The support the internationalisation of the research environment at the Institute of Microbiology of the Czech Academy of sciences through the transfer of foreign experience by involving researchers from abroad. Within this project Marie Skłodowska-Curie Actions research projects of type “MSCA Postdoctoral Fellowships” of three researchers coming from abroad will be implemented. These research projects achieved at least 70% of the total score in the Horizon Europe evaluation but could not be funded from this program due to lack of funding. The planned 24-month mobility funded from program OP JAK will strengthen the professional growth of the supported researchers.

The project is financially supported by the European Union.

 

 

_________________________________________________________________________________________

 

Project title:

MSCA Fellowships CZ (Institute of Microbiology of the CAS, v. v. i.)

Provider	Ministry of Education, Youth and Sports
Operational Program	Johannes Amos Comenius Programme
Project number	CZ.02.01.01/00/22_010/0002357
Project duration	1.1.2023 – 30.6.2025
Beneficiary	Institute of Microbiology of the CAS, v.v.i.

 

Objectives of the project:

The project will support Marie Skłodowska-Curie Actions research projects of the type “MSCA Postdoctoral Fellowships” of three researchers coming from abroad. These research projects achieved at least 70% of the total score in the Horizon Europe evaluation but could not be funded due to lack of funding. The implementation of this project will strengthen the internationalisation of the research environment at our institution and the professional growth of the supported researchers.

The project is financially supported by the European Union.

 

 

---

 

 

—— RRF Projects – EXCELES programme ——

 

 

The EXCELES programme aims to increase the capacity of research capacities to respond to current trends and needs in the field of research, development and innovation in relation to the emergence of major diseases with statistically highest mortality or high direct (medical) and indirect (social and economic) costs, as well as to the impacts and complications of these diseases caused by covid-19 diseases, and to the social and economic impacts of systemic health risks associated with these diseases.

EXCELES projects are funded by a grant from the Ministry of Education, Youth and Sports under the EXCELES programme, which aims to support excellent research in priority areas of public interest in the health sector. The EXCELES programme is funded by the European Union through the Recovery and Resilience Facility (RRF) – NextGeneretionEU.

 

Name of the project:

National Institute for Cancer Research (NICR) 

Project number	LX22NPO5102
Beneficiary	Charles University
Principal investigator	prof. MUDr. Aleksi Šedo, DrSc.
Start of the project	06/2022
End of the project	12/2025
Number of co-beneficiaries (coinvestigators)	11, IMIC is a co-beneficiary (coinvestigator)
Coinvestigator for IMIC	RNDr. Marek Kovář, Ph.D.

 

 

Project objectives:

The main objective of the project is to establish and build the National Institute for Cancer Research (NICR) as a new national scientific authority in the field of cancer research. The NICR will enable the creation of a nationwide network of collaborating institutions conducting cutting-edge cancer research. Oncology research is currently not sufficiently coordinated and is fragmented across institutions that do not collaborate and do not use the available research infrastructure efficiently and effectively enough. The thematic and especially infrastructural complementarity of individual departments within the NICR will make it possible to remedy this situation and thus achieve the complexity of approach that is essential for modern oncology research. Cancer research will become much more coordinated, strategic and efficient at the national level through the creation of the NICR, which will increase its quality and thus its international competence.

 

_________________________________________________________________________________________

 

Name of the project:

National Institute of Virology and Bacteriology (NIVB)

Project number	LX22NPO5103
Beneficiary	Institute of Organic Chemistry and Biochemistry of the CAS, v.v.i.
Principal investigator	RNDr. PhDr. Zdeněk Hostomský, CSc.
Start of the project	06/2022
End of the project	12/2025
Number of co-beneficiaries (coinvestigators)	8, IMIC is a co-beneficiary (coinvestigator)
Coinvestigator for IMIC	prof. Ing. Peter Šebo, CSc.

 

 

Project objectives:

The National Institute of Virology and Bacteriology (NIVB) aims to make discoveries in infectious diseases that will improve human health, develop safe and effective antiviral and antibacterial therapies, and prepare platforms for future drug discovery and development against viruses and bacteria with pandemic potential.

NIVB pursues cutting-edge research in the areas of (1) pathogen-host interactions, (2) immunity against viruses and bacteria, and (3) treatment of viral and bacterial infections. By working with pathogens that are relevant to current clinical practice, as well as emerging viruses and bacteria, the Institute’s research groups will be able to provide the expertise and facilities to study new pathogens that may spread to the human population in the future. The NIVB will thus become a national authority and knowledge partner for public authorities in this respect.

 

---

 

—— Horizon Europe Projects ——

Name of the project:

Central Bohemia Mobility Programme for Excellence in Research, Innovation and Technology

 

Acronym	MERIT
Number and ID code of the project	101081195 – HORIZON-MSCA-COFUND-2021
Type of the project	HORIZON EUROPE MSCA – COFUND
Coordinator	Central Bohemian Innovation Center, Czech Republic
IMIC Principal Researcher	RNDr. Petr Novák, Ph.D.
Start of the project	01/2023
End of the project	12/2027
Total number of particip. countries	1
Of which from EU	1
Number of partners	15
Total funding for the project	5 985 000,00 EUR, of which 3 582 000.00 EUR from the EU
Funding for IMIC	95 520 EUR from EU
Provider	Program EU Horizon Europe HORIZON-MSCA-COFUND-2021, Central Bohemia Region

 

Objective of the project:

MERIT has 3 strategic objectives: 1) Strengthen the European and global human capital base in research and innovation and contribute to a stronger European Research Area; 2) Establish new partnerships and collaborations between academic and non-academic sectors; and 3) Promote science and its many practical applications in society among the youth and advocate for more representation of women in technical and life sciences. The programme offers research opportunities accross 5 main application areas: Biotechnology/Biomedicine, Laser technologies, Space technologies, Sustainable energy/Materials and Digitalisation/AI. 2 calls for applicants are planned offering in total 30 fellowships for up to 30 months, including secondments with the duration from 2 to 9 months. There are 15 Hosting organisations and 35 different research groups involved in MERIT.

 

_________________________________________________________________________________________

 

Name of the project:

The Next Generation MS SPIDoc’s

 

Acronym	SPIDoc’s
Number and ID code of the project	101120312 – HORIZON-MSCA-2022-DN-01
Type of the project	HORIZON TMA MSCA Doctoral Networks
Coordinator	UNIVERSITAET SIEGEN, Germany
IMIC Principal Researcher	RNDr. Alan Kádek, Ph.D.
Start of the project	9/2023
End of the project	8/2027
Total number of particip. countries	5
Of which from EU	5
Number of partners	6
Total funding for the project	2 711 880 EUR
Funding for IMIC	237 038,40 EUR
Provider	Program EU Horizon Europe – HORIZON-MSCA-2022-DN-01

 

Objective of the project:

SPIDoc’s project aims to train the next generation of scientists specialized in structural biology technologies, which include a cutting-edge approach combining mass spectrometry (MS) and X-ray single particle imaging (SPI) at MS SPIDOC. These technologies will allow a better knowledge of the dynamic nature of viral structures, which is necessary to determine the appropriate treatments. SPIDoc projects are specialized, highly interlinked and the proposed interdisciplinary training program aims to provide doctoral candidates with basic and advanced knowledge to build a common interdisciplinary language, to work in teams and to acquire deep knowledge through a combination of lectures and practical exercises. An important aspect will be given to data management and the creation of currently missing standards for MS native metadata.

 

_________________________________________________________________________________________

 

Name of the project:

Two-dimensional acquisition for top-down native mass spectrometry of non-covalent protein complexes

 

Acronym	2D-TOPMASS
Number and ID code of the project	N° 101090276, HORIZON-WIDERA-2022-TALENTS-02
Type of the project	HORIZON-TMA-MSCA-PF-EF
Coordinator	Institute of Microbiology of the CAS, v.v.i.
IMIC Principal Researcher	RNDr. Alan Kádek, Ph.D.
Start of the project	7/2023
End of the project	6/2025
Total number of particip. countries	1
Of which from EU	1
Number of partners	0
Total funding for the project	166 278,72 EUR
Funding for IMIC	166 278,75 EUR
Provider	Program EU Horizon Europe HORIZON-WIDERA-2022-TALENTS-02

 

Objective of the project:

Native mass spectrometry is a powerful structural biology tool to study protein complexes, their dynamics and composition. In its so-called top-down approach, it aims to link specific forms of proteins to higher assemblies, in which they function naturally and/or in a disease. The 2D-TOPMASS project will leverage the power and versatility offered by state-of-the-art Fourier transform ion cyclotron resonance mass spectrometry experimentally coupled to powerful ultraviolet and infrared laser ion activation techniques in combination with advanced two-dimensional acquisition schemes in order to push the boundaries of native top-down MS of large protein- and protein / nucleic acid complexes.

 

_________________________________________________________________________________________

 

Name of the project:

DiAMonD – DIscovering Active MicroOrgaNisms implicated in adverse Drug effects

 

Acronym	DiAMonD
Number and ID code of the project	N° 101090267, HORIZON-WIDERA-2022-TALENTS-02
Type of the project	HORIZON-TMA-MSCA-PF-EF
Coordinator	Institute of Microbiology of the CAS, v.v.i.
IMIC Principal Researcher	dr. Zaki Saati Santamaría
Start of the project	7/2024
End of the project	6/2026
Total number of particip. countries	1
Of which from EU	1
Number of partners	0
Total funding for the project	166 278,72 EUR
Funding for IMIC	166 278,75 EUR
Provider	Program EU Horizon Europe HORIZON-WIDERA-2022-TALENTS-02

 

Objective of the project:

The microbiome plays relevant functions on human health and disease, including roles in the efficacy and security of drug treatments. Capecitabine is a pro-drug of 5-fluorouracil, which is an active metabolite that targets tumor cells. This treatment is used for diverse cancers, including colon tumors, and is commonly associated with diverse adverse reactions such as the hand-foot syndrome (HFS), a skin deterioration for which there has not been discovered its causal mechanism. Preliminary data suggest that some skin microbes interact with 5-flourouracil.

In this project, the researcher will focus on studying the dynamics and features of the skin microbiome of patients treated with capecitabine. This project will provide understanding related with the roles of the skin microbiome in the appearance or protection against a skin adverse drug reaction. This knowledge may be used for the advance of a precise and personalized medicine in which the individual microbiome can be considered.

 

---

 

—— Horizon 2020 Projects ——

 

Title of the Framework Program: Horizon 2020

Name of the project:

Joining forces to exploit the mycobiota of Asia, Africa and Europe for beneficial metabolites and potential biocontrol agents, using – OMICS techniques

Acronym	MYCOBIOMICS
Number and ID code of the project	N° 101008129, H2020-MSCA-RISE-2020
Type of the project	MSCA-RISE
Coordinator	Helmholtz-Zentrum für Infektionsforschung GmbH
IMIC Principal Researcher	Mgr. Miroslav Kolařík, PhD.
Start of the project	4/2021
End of the project	9/2025
Total number of particip. countries	4
Of which from EU	4
Number of partners	4
Total funding for the project	1 375 400 EUR
Funding for IMIC	289 800 EUR
Provider	Program EU Horizon 2020 MSCA-RISE-2020 – Research and Innovation Staff Exchange

 

Objective of the project:

The overall aim of the project is to exploit the mycobiota of Asia, Africa and Europe for beneficial metabolites and potential biocontrol agents, using -OMICS techniques. This also includes discovery of new taxa and bioactive molecules applicable in biotechnology and medicine. In the course of the project, partners from Austria, Czechia, Netherlands and South Africa will share knowledge, train students and disseminate results.

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:

Holistic management practices, modelling and monitoring for European forest soils

Acronym	HoliSoils
Number and ID code of the project	N°101000289, H2020-SFS-2020-2
Type of the project	RIA
Coordinator	Natural Resources Institute Finland (Luke), Finland
IMIC Principal Researcher	RNDr. Petr Baldrian, Ph.D.
Start of the project	5/2021
End of the project	10/2025
Total number of particip. countries	13
Of which from EU	10
Number of partners	19
Total funding for the project	9 999 920 EUR
Funding for IMIC	843 250 EUR
Provider	Program EU Horizon 2020 LC-SFS-22-2020 – Forest soils Research and Innovation Action

 

Objective of the project:

Knowledge gaps on forest soil processes and lack of a harmonised soil monitoring limit the EU’s ability to maintain soil related ecosystem services and to reach climate policy targets. A better understanding of the soil processes and a harmonised approach to manage and integrate data to computational models that are used for decision making is urgently required in order to meet climate and sustainability goals. The project HoliSoils aims to develop tools for soil monitoring, refine assessment of greenhouse gas (GHG) fluxes, enhance efficiency of GHG mitigation actions, and improve numerical forecasting of soil-based mitigation, adaptation, and ecosystem services. HoliSoils applies a collaborative multi-actor approach, in order to maximise its applicability and impact beyond its duration. The multidisciplinary consortium consists of universities and research institutes from across Europe, with leading expertise on soil analysis and databases, development of advanced analytical techniques, complex system modelling, digital soil mapping, soil ecology, disturbance ecology, forest and GHG inventories, social sciences, and communications. It also involves active engagement with diverse stakeholders, including forest owners and managers, industry actors, forest extension services, a certification body, forest and soil researchers, climate policy support and GHG inventory experts, and policymakers. Within the consortium, Institute of Microbiology leads the workpackage that characterizes forest soil biodiversity, soil properties and processes.

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:

ALGAE4IBD – from nature to bedside – algae based bio compound for prevention and treatment of inflammation, pain and IBD

Acronym	Algae4IBD
Number and ID code of the project	N° 101000501, H2020-FNR-2020-2
Type of the project	RIA
Coordinator	MIGAL GALILEE RESEARCH INSTITUTE LTD, Israel
IMIC Principal Researcher	RNDr. Pavel Hrouzek, Ph.D.
Start of the project	6/2021
End of the project	5/2025
Total number of particip. countries	11
Of which from EU	9
Number of partners	20
Total funding for the project	7 499 520,01 EUR
Funding for IMIC	271 995 EUR
Provider	Program EU Horizon 2020 FNR-11-2020 – Prospecting aquatic and terrestrial natural biological resources for biologically active compounds

 

Objective of the project:

Inflammatory bowel disease (IBD), including the Crohn´s disease, is one of the most important civilization disorder nowadays. Algae4IBD’s mission is to discover algal and cyanobacterial bioactive compounds reducing the inflammatory response and simultaneously silencing other IBD symptoms. The biomass of algal strains producing such compound will be used for preparation of functional food used in treatment and prevention of IBD. International consortium led by Israeli colleagues includes scientist from 21 European institutions with different expertise ranging from natural product chemistry, pharmacology, drug administration to functional food preparation.

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:

Response of soil microbial communities to climate warming: from local to global scale

Acronym	MicroWar
Number and ID code of the project	N° 101028243, H2020-MSCA-IF-2020
Type of the project	MSCA-IF-EF-RI
Coordinator	Institute of Microbiology of the CAS, v.v.i., Czech Republic
IMIC Principal Researcher	RNDr. Jana Voříšková, Ph.D.
Start of the project	6/2021
End of the project	29.9.2027
Total number of particip. countries	1
Of which from EU	1
Number of partners	0
Total funding for the project	156 980,64 EUR
Funding for IMIC	156 980,64 EUR
Provider	Program EU Horizon 2020 MSCA-IF-2020 – Individual Fellowships

 

Objective of the project:

Global warming represents one of the most complex issues of the present time and climate models predict further increase of temperature in the next decades. However, the extent of microbial response to predicted climate change and the consequences on stability of soil carbon and its possible release into the atmosphere as carbon dioxide and methane represent a major knowledge gap. The aim of MicroWar project is to characterize the response of soil microbial communities to simulated warming in arctic tundra soils by combination of in situ ecosystem manipulation experiments with metagenomic approaches. Further the project aims to assess the response of soil microbial taxa to climate warming manipulations worldwide by meta-analytical synthesis using published data.

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:

Redesigning the Photosynthetic Light Reactions

Acronym	PhotoRedesign
Number and ID code of the project	N°854126, ERC-2019-SyG
Type of the project	ERC-SyG
Coordinator	LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN, Germany
IMIC Principal Researcher	prof. RNDr. Josef Komenda, CSc., DSc.
Start of the project	4/2020
End of the project	3/2026
Total number of particip. countries	3
Of which from EU	3
Number of partners	2
Total funding for the project	7 496 829 EUR
Funding for IMIC	2 498 861 EUR
Provider	Program EU Horizon 2020 ERC-SyG – Synergy grant

 

Objective of the project:

Photosynthesis is a key natural process that uses the energy of sunlight to develop the oxygen we breathe and to produce biomass, which we use as food, feed and energy. However, plants, algae and cyanobacteria are able to absorb only part of this energy, there are significant energy losses during the process and the light also constantly damages the photosynthetic apparatus. Improved ability of photosynthetic organisms to absorb energy, its more efficient use and increased resistance to damage could significantly improve food and energy production, which are key challenges facing humanity. Contrary to current approaches, this project seeks to address these challenges by creating a new cyanobacterial-based organism that contains a combination of synthetic components and the most effective parts of the photosynthetic apparatus from different organisms: photosynthetic bacteria, cyanobacteria and plants. This combination ensures a unique ability to absorb most of the sun’s radiation, increase energy gain from it and better resistance to light damage. The project will use the complementary expertise of the participating teams in molecular, synthetic and structural biology, biochemistry and biophysics of both bacterial and plant photosynthesis. The project should create a completely new concept of modification and optimization of complex biological processes such as photosynthesis, which are seemingly unchangeable due to their complexity. The PhotoRedesign project should lay the foundations for a major improvement in the productivity of economically important photosynthetic organisms, from the simplest cyanobacteria to agricultural crops.

 

 

---

 

Title of the Framework Program: Horizon 2020

Name of the project:

A sustainable multi-strain, multi-method, multi-product microalgae biorefinery integrating industrial side streams to create high-value products for food, feed and fragrance

Acronym	MULTI-STR3AM
Number and ID code of the project	N°887227, H2020-BBI-JTI-2019
Type of the project	BBI-IA-DEMO
Coordinator	A4F ALGAFUEL SA, Portugalsko
IMIC Principal Researcher	Ing. Jiří Kopecký, CSc.
Start of the project	5/2020
End of the project	4/2025
Total number of particip. countries	3
Of which from EU	3
Number of partners	7
Total funding for the project	6 588 732 EUR
Funding for IMIC	698 400 EUR
Provider	Program EU Horizon 2020 BBI-IA-DEMO – Bio-based Industries Innovation action – Demonstration

 

Objective of the project:

The MULTI-STR3AM project responds to the growing demand for sustainable microalgae products. As the first European project, it is based on the so-called “MULTI-biorefinery” approach, which means the integration of multiple strains, multiple processes and multiple products into one common technology. The consortium includes two companies – Algae for Future (Portugal) and Phycom (Netherlands), which will produce biomass for the preparation of requiered high-quality products such as lipids for feed and food applications; algal protein for feed and cosmetic applications; pigments for food and feed, and low molecular weight organic compounds for cosmetics. The project includes seven work packages covering the entire production process, from biomass production through the integration of individual technologies into three main processing directions, to the final products for three large end users (For Farmers, International Flavors and Fragrances and Upfield). The MULTI-STR3AM project naturally focuses on reducing investment and operating costs for biomass production of microalgae and downstream processing. The role of the team of the Institute of Microbiology of the Czech Academy of Sciences in the project is to obtain new strains, including breeding (non-GMO), proposals for cultivation protocols and the use of chromatography for the isolation of valuable substances..

 

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:

Structural insights into binding signatures of transcription factors regulated by HIPPO signalling

 

Acronym	HIPPOSTRUCT
Number and ID code of the project	N°101003406, H2020-WF-02-2019
Type of the project	MSCA-IF-EF-ST
Coordinator	Institute of Microbiology of the CAS, v.v.i.
IMIC Principal Researcher	Ing. Aleš Hnízda, Ph.D.
Start of the project	6/2020
End of the project	5/2022
Total number of particip. countries	1
Of which from EU	1
Number of partners	0
Total funding for the project	156 980,64 EUR
Funding for IMIC	156 980,64 EUR
Provider	Program EU Horizon 2020 MSCA-IF-EF-ST – Standard EF

 

Objective of the project:

The aim of this project is to analyze the cooperative binding of transcription factors (TFs), which are regulated by the HIPPO signaling pathway. We will focus mainly on TFs from the TEAD and FOX groups, which probably work together to regulate the same transcription programs. We will use a bioinformatic search of the human genome followed by experimental analysis of intermolecular interactions between TF and DNA, which will be followed by structural analysis of selected macromolecular complexes. The results will provide information on the mechanisms by which TFs cooperate in relevant sections of the genome with the corresponding chromatin architecture.

Final Report of the project: HERE

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:

PERtussIS COrrelates of Protection Europe

 

Acronym	PERISCOPE
Number and ID code of the project	N°115910, H2020JTI-IMI2-2015-03-two stage
Type of the project	IMI2-2015-03-05 – Vaccines
Coordinator	Radboud University Medical Center, Holland
IMIC Principal Researcher	Prof. Ing. Peter Šebo, CSc.
Start of the project	3/2016
End of the project	8/2022
Total number of particip. countries	9
Of which from EU	8
Number of partners	22
Total funding for the project	21 000 000 EUR
Funding for IMIC	300 000 EUR
Provider	Innovative Medicines Initiative 2 Joint Undertaking, které získalo podporu z programu EU Horizon 2020 Research and Innovations a EFPIA (The European Federation of Pharmaceutical Industries and Associations) a BMGF (Bill and Melinda Gates Foundation)

 

Objective of the project:

The overall objective of the PERISCOPE consortium is to accelerate the development and registration of novel pertussis vaccines. Pivotal to this is the identification of novel biomarkers of protection and the development of models that can be used to expedite preclinical and clinical testing, and selection of the most effective candidates for licensing.

More information: https://periscope-project.eu/

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:  

Sustainable Algae Biorefinery for Agriculture aNd Aquaculture

 

Acronym	SABANA
Number and ID code of the project	N°727874, H2020-BG-2016-2017/H2020-BG-2016-1
Type of the project	IA
Coordinator	UNIVERSITY OF ALMERIA, Spain
IMIC Principal Researcher	prof. RNDr. Jiří Masojídek, CSc.
Start of the project	12/2016
End of the project	11/2021
Total number of particip. countries	5
Of which from EU	5
Number of partners	10
Total funding for the project	8 848 523,75 EUR
Funding for IMIC	549 750 EUR (of which EUR 170 000 to the linked third party National Research Council, Italy)
Provider	Program EU Horizon 2020 Research and Innovations

 

Objective of the project:

Project aims at developing a large-scale integrated microalgae-based biorefinery for the production of biostimulants, biopesticides and feed additives, in addition to biofertilizers and aquafeed, using only marine water and nutrients from wastewaters (sewage, centrate and pig manure). The objective is to achieve a zero-waste process at a demonstration scales up to 5 ha sustainable both environmentally and economically.

 

More information: http://www.eu-sabana.eu/

 

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:

European Network of Fourier-Transform Ion-Cyclotron-Resonance Mass Spectrometry Centers

 

Acronym	EU_FT-ICR_MS
Number and ID code of the project	N°731077, H2020-INFRAIA-2017-1-two-stage
Type of the project	RIA
Coordinator	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS, France
IMIC Principal Researcher	RNDr. Petr Novák, PhD
Start of the project	1/2018
End of the project	12/2022
Total number of particip. countries	9
Of which from EU	8
Number of partners	11
Total funding for the project	4 988 746,50 EUR
Funding for IMIC	542 265,75 EUR
Provider	Program EU Horizon 2020 Research and Innovations

 

 

4 objectives of the project:

1. Provide the EU academic, SME and industrial communities’ with access to world-class FT-ICR MS centers.
2. Build an EU community of end-users and FT-ICR MS scientists.
3. Open access to data and open source software to the EU FT-ICR MS network.
4. Strengthen the FT-ICR MS application fields by promoting innovative and cooperative research between European FT-ICR MS academic scientists and private companies (instrumentation and software).

More information: http://eu-fticr-ms.eu/

 

 

_________________________________________________________________________________________

 

Title of the Framework Program: Horizon 2020

Name of the project:

European Proteomics Infrastructure Consortium Providing Access

 

Acronym	EPIC-XS
Number and ID code of the project	N°823839, H2020-INFRAIA-2018-1
Type of the project	RIA
Coordinator	Utrecht University, Holandsko
IMIC Principal Researcher	RNDr. Petr Novák, PhD
Start of the project	1/2019
End of the project	6/2023
Total number of particip. countries	15
Of which from EU	13
Number of partners	18
Total funding for the project	9 986 185,75 EUR
Funding for IMIC	474 125 EUR (of which EUR 90 125 for the linked third party Masaryk University).
Provider	Program EU Horizon 2020 Research and Innovations

 

Objective of the project:

Project brings together a consortium of world-leading, highly innovative European proteomics facilities with the shared goal of supporting excellent life sciences research in Europe. Project will provide scientists transnational access to high end proteomics technologies and resources, will strengthen and expand the European proteomics community through its expertise in proteomics. Project will develop and implement novel mass spectrometry based proteomics and bioinformatics approaches. It’s excellent training courses and programs, available to both novices and experts, will attract new research communities who will be schooled in advanced proteomics technologies.

 

More information: https://epic-xs.eu

 

---

—— OP VVV Projects ——

 

Project title:

International mobility of researchers – MSCA-IF IV (Institute of Microbiology of the CAS, v. v. i.)

Provider	Ministry of Education, Youth and Sports
Operational Program	Operational Programmme Research, Development and Education
Project number	CZ.02.2.69/0.0/0.0/20_079/0017812
Project duration	1.1.2021 – 31.1.2023
Beneficiary	Institute of Microbiology of the CAS, v.v.i.

 

Objectives of the project:

The project will support three MSCA projects – arrivals to the Czech Republic approved at the European level from Horizon 2020, Marie Skłodowska-Curie Actions, which were listed in the “no-money” list.

The project is financially supported by the European Union.

 

_________________________________________________________________________________________

 

Project title:

International mobility of researchers of the Institute of Microbiology of the CAS, v. v. i. No 2

Provider	Ministry of Education, Youth and Sports
Operational Program	Operational Programme Research, Development and Education
Project number	CZ.02.2.69/0.0/0.0/18_053/0017705
Project duration	1.1.2021 – 31.1.2023
Beneficiary	Institute of Microbiology of the CAS, v.v.i.

 

Objectives of the project:

The general objective of the project is the internationalization and strengthening of IM research. For outbound mobility, the project is aimed at supporting the professional development of young IM researchers through acquiring new experience and practices abroad, and supporting high-quality senior IM researchers in their further professional growth. For inbound mobility, the project is aimed at utilizing the potential of post-docs from abroad within the IM and transferring foreign experience of high-quality senior researchers to IM. A total of 19 mobilities are planned within the project. The presentation of results and the establishment of contacts will be promoted by attendance at foreign conferences and dissemination seminars.

The project is financially supported by the European Union.

 

_________________________________________________________________________________________

 

Project title

International mobility of researchers – MSCA-IF III (Institute of Microbiology of the CAS, v. v. i.)

Provider	Ministry of Education, Youth and Sports
Operational Program	Operational Programme Research, Development and Education
Project number	CZ.02.2.69/0.0/0.0/19_074/0014484
Project duration	1.1.2020 – 31.12.2021
Beneficiary	Institute of Microbiology of the CAS, v. v. i.

 

Objectives of the project:

The general objective of the project is the development of human resources in research at the Institute of Microbiology of the Czech Academy of Sciences, v. v. i. The project supports the project of inbound mobility of a researcher approved at European level from Horizon 2020, Marie Skłodowska-Curie Actions, which was listed in the “no-money” list.

The project is financially supported by the European Union

 

_________________________________________________________________________________________

 

Project title:

ELIXIR-CZ: Capacity Building

Provider	Ministry of Education, Youth and Sports
Operational Program	Operational Programme Research, Development and Education
Project number	CZ.02.1.01/0.0/0.0/16_013/0001777
Project duration	1.5.2017 – 30.4.2021
Beneficiary	Masaryk University in Brno

 

https://www.muni.cz/research/projekty/37550

The project is financially supported by the European Union.

 

_________________________________________________________________________________________

 

Project title:

Modernization and support of research activities of the national infrastructure for translational medicine EATRIS-CZ

Provider	Ministry of Education, Youth and Sports
Operational Program	Operational Programme Research, Development and Education
Project number	CZ.02.1.01/0.0/0.0/16_013/0001818
Project duration	1.6.2017 – 31.5.2019
Beneficiary	Palacký University Olomouc

http://www.psup.cz/modernizace-a-podpora-vyzkumnych-aktivit-narodni-infrastruktury-pro-translacni-medicinu-eatris-cz/

The project is financially supported by the European Union.

 

_________________________________________________________________________________________

 

Project title:

International mobility of researchers – MSCA-IF (Institute of Microbiology of the Czech Academy of Sciences, v. v. i.)

Provider	Ministry of Education, Youth and Sports
Operational Program	Operational Programme Research, Development and Education
Project number	CZ.02.2.69/0.0/0.0/17_050/0008376
Project duration	1.6.2018 – 31.7.2021
Beneficiary	Institute of Microbiology of the CAS, v.v.i.

 

Objectives of the project:

The general objective of the project is the development of human resources in research at the Institute of Microbiology of the Academy of Sciences of the Czech Republic, v. v.i. The project supports the inbound mobility of a researcher approved at European level from Horizon 2020, Marie Skłodowska-Curie Actions, which was listed in the “no-money” list.

The project is financially supported by the European Union.

 

_________________________________________________________________________________________

 

Project title:

International mobility of researchers of the Institute of Microbiology of the CAS, v. v. i.

Provider	Ministry of Education, Youth and Sports
Operational Program	Operational Programme Research, Development and Education
Project number	CZ.02.2.69/0.0/0.0/16_027/0007990
Project duration	1.1.2018 – 31.7.2020
Beneficiary	Institute of Microbiology of the CAS, v.v.i.

 

Objectives of the project:

The general objective of the project is the internationalization and strengthening of IM research. For outbound mobility, the project is aimed at supporting the professional development of young rookie IM researchers through acquiring new experience and practices abroad, and supporting high-quality senior IM researchers in their further professional growth. For inbound mobility, the project is aimed at utilizing the potential of post-docs from abroad within the IM and transferring foreign experience of high-quality senior researchers to IM. Within the project, 7 items of inbound mobility and 7 items of outbound mobility will be implemented. The presentation of results and the establishment of contacts will be promoted by attendance at foreign conferences and dissemination seminars.

The project is financially supported by the European Union

 

_________________________________________________________________________________________

 

Project title:

International mobility of researchers – MSCA-IF II (Institute of Microbiology of the CAS, v. v. i.)

Provider	Ministry of Education, Youth and Sports
Operational Program	Operational Programme Research, Development and Education
Project number	CZ.02.2.69/0.0/0.0/18_070/0010493
Project duration	1.9.2018 – 31.8.2020
Beneficiary	Institute of Microbiology of the CAS, v.v.i.

 

Objectives of the project:

The general objective of the project is the development of human resources in research at the Institute of Microbiology of the Academy of Sciences of the Czech Republic, v.v.i. The project supports the project of inbound mobility of a researcher approved at European level from Horizon 2020, Marie Skłodowska-Curie Actions, which was listed in the “no-money” list.

The project is financially supported by the European Union

Provider	Ministry of Industry and Trade
Operational Program	Operational Program Enterprise and Innovation for Competitiveness – APPLICATION program
Priority axis	PO 1 – Development of research and development for innovation
Project number	CZ.01.1.02/0.0/0.0/15_019/0004960
Project duration	1.1.2017 – 30.9.2019
Main recipient	GEN-TREND s.r.o.

 

http://www.gentrend.cz/sluzby/molekularni-biologie-vyzkum-a-vyvoj/evropsky-fond-pro-regionalni-rozvoj-op-podnikani-a-inovace-p/

 

 

_________________________________________________________________________________________

 

Project title:

Research and development activities of TriLAB Group s.r.o. using delta kinematics 3D printing technology for new 3D printing applications

[

Provider	Ministry of Industry and Trade
Operational Program	Enterprise and Innovation for Competitiveness
Priority axis	PO 1 – Development of research and development for innovation
Project number	CZ.01.1.02/0.0/0.0/17_107/0011449
Project duration	2.10.2017 – 31.12.2020
Main recipient	TriLAB Group s.r.o.

 

Objectives of the project:

The object of the project is the research and development activities leading to the creation of a prototype of a new product – a solution based on delta kinematics and its subsequent application not only for FDM printing in science and research, education and industry

 

 

_________________________________________________________________________________________

 

Project title:

Research and development of the sanitary complex for people with movement restrictions

Provider	Ministry of Industry and Trade
Operational Program	Operational Program Enterprise and Innovation for Competitiveness
Priority axis	PO 1 – Development of research and development for innovation
Project number	CZ.01.1.02/0.0/0.0/16_084/0010359
Project duration	20.4.2017 – 31.12.2019
Main recipient	Alca plast, s.r.o.

 

Objectives of the project:

The subject of the project is the research and development of a sanitary complex, primarily intended for people with movement restrictions. The essence of the product that is being developed is a height-adjustable toilet, which allows for use by both people with temporary movement restrictions and those permanently attached to a wheelchair.

 

About the project
Project Registration Number	CZ.1.05/1.1.00/02.0109
Název projektu	Project title: Biotechnology and Biomedical Center of the Academy of Sciences and Charles University in Vestec (BIOCEV) *
Číslo projektu	* BIOCEV is an official, initialized abbreviation of the project

BIOCEV is a joint project of six institutes of the Academy of Sciences of the Czech Republic (Institute of Molecular Genetics, Institute of Biotechnology, Institute of Microbiology, Institute of Physiology, Institute of Experimental Medicine and Institute of Macromolecular Chemistry) and two faculties of Charles University in Prague (Faculty of Science and First Faculty of Medicine) whose aim is the realization of a science center of excellence in the fields of biotechnology and biomedicine. The main source of funding for the construction of the Center is the European Regional Development Fund, from which the funds are provided through the Operational Program Research and Development for Innovation from Priority Axis 1 – European Centers of Excellence.